Integration of the recently announced joint ventures with Harbin Pharmaceutical Group ("Harbin") and International Vitamin Corporation ("IVC") currently on track with expectations
Retired legacy B-1 Term Loan on March 4th and reduced the extended B-2 Term Loan during the first quarter of 2019 by $114 million. In aggregate, retired over $350 million in debt since beginning of fourth quarter of 2018.
Ended first quarter with $211 million in liquidity
Recently launched CBD topical products in 23 states and the District of Columbia
GNC brand mix increased to 52% compared with 50% in the first quarter of 2018
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.